Global Red Biotechnology Market Insights, Forecast to 2030

Publication ID:

PB512248559

Publication Date:

December 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Red biotechnology听is also known as biopharmaceuticals. It involves the application of biotechnology to produce medicine and drugs.
Market Analysis and Insights: Global Red Biotechnology Market
The global Red Biotechnology market is projected to grow from US$ 293580 million in 2024 to US$ 358800 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.
The US & Canada market for Red Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Red Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Red Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Red Biotechnology include F. Hoffmann-La Roche, Amgen, Gilead Sciences, CSL and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Red Biotechnology is widely used in various fields, such as Biopharmaceutical Production, Gene Therapy and Pharmacogenomics and Genetic Testing,, etc. Biopharmaceutical Production provides greatest supports to the Red Biotechnology industry development. In 2023, global % revenue of Red Biotechnology went into Biopharmaceutical Production filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Red Biotechnology market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Red Biotechnology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Red Biotechnology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Red Biotechnology revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Red Biotechnology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Red Biotechnology revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer
Segment by Type
Antibody
Nucleic Acid
Protein
Other
Segment by Application
Biopharmaceutical Production
Gene Therapy
Pharmacogenomics and Genetic Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Red Biotechnology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Red Biotechnology companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Red Biotechnology revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Red Biotechnology Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Antibody
1.2.3 Nucleic Acid
1.2.4 Protein
1.2.5 Other
1.3 Market by Application
1.3.1 Global Red Biotechnology Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Production
1.3.3 Gene Therapy
1.3.4 Pharmacogenomics and Genetic Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Red Biotechnology Market Perspective (2019-2030)
2.2 Global Red Biotechnology Growth Trends by Region
2.2.1 Red Biotechnology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Red Biotechnology Historic Market Size by Region (2019-2024)
2.2.3 Red Biotechnology Forecasted Market Size by Region (2025-2030)
2.3 Red Biotechnology Market Dynamics
2.3.1 Red Biotechnology Industry Trends
2.3.2 Red Biotechnology Market Drivers
2.3.3 Red Biotechnology Market Challenges
2.3.4 Red Biotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Red Biotechnology by Players
3.1.1 Global Red Biotechnology Revenue by Players (2019-2024)
3.1.2 Global Red Biotechnology Revenue Market Share by Players (2019-2024)
3.2 Global Red Biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Red Biotechnology, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Red Biotechnology Market Concentration Ratio
3.4.1 Global Red Biotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Red Biotechnology Revenue in 2023
3.5 Global Key Players of Red Biotechnology Head office and Area Served
3.6 Global Key Players of Red Biotechnology, Product and Application
3.7 Global Key Players of Red Biotechnology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Red Biotechnology Breakdown Data by Type
4.1 Global Red Biotechnology Historic Market Size by Type (2019-2024)
4.2 Global Red Biotechnology Forecasted Market Size by Type (2025-2030)
5 Red Biotechnology Breakdown Data by Application
5.1 Global Red Biotechnology Historic Market Size by Application (2019-2024)
5.2 Global Red Biotechnology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Red Biotechnology Market Size (2019-2030)
6.2 North America Red Biotechnology Market Size by Type
6.2.1 North America Red Biotechnology Market Size by Type (2019-2024)
6.2.2 North America Red Biotechnology Market Size by Type (2025-2030)
6.2.3 North America Red Biotechnology Market Share by Type (2019-2030)
6.3 North America Red Biotechnology Market Size by Application
6.3.1 North America Red Biotechnology Market Size by Application (2019-2024)
6.3.2 North America Red Biotechnology Market Size by Application (2025-2030)
6.3.3 North America Red Biotechnology Market Share by Application (2019-2030)
6.4 North America Red Biotechnology Market Size by Country
6.4.1 North America Red Biotechnology Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Red Biotechnology Market Size by Country (2019-2024)
6.4.3 North America Red Biotechnology Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Red Biotechnology Market Size (2019-2030)
7.2 Europe Red Biotechnology Market Size by Type
7.2.1 Europe Red Biotechnology Market Size by Type (2019-2024)
7.2.2 Europe Red Biotechnology Market Size by Type (2025-2030)
7.2.3 Europe Red Biotechnology Market Share by Type (2019-2030)
7.3 Europe Red Biotechnology Market Size by Application
7.3.1 Europe Red Biotechnology Market Size by Application (2019-2024)
7.3.2 Europe Red Biotechnology Market Size by Application (2025-2030)
7.3.3 Europe Red Biotechnology Market Share by Application (2019-2030)
7.4 Europe Red Biotechnology Market Size by Country
7.4.1 Europe Red Biotechnology Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Red Biotechnology Market Size by Country (2019-2024)
7.4.3 Europe Red Biotechnology Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Red Biotechnology Market Size (2019-2030)
8.2 China Red Biotechnology Market Size by Type
8.2.1 China Red Biotechnology Market Size by Type (2019-2024)
8.2.2 China Red Biotechnology Market Size by Type (2025-2030)
8.2.3 China Red Biotechnology Market Share by Type (2019-2030)
8.3 China Red Biotechnology Market Size by Application
8.3.1 China Red Biotechnology Market Size by Application (2019-2024)
8.3.2 China Red Biotechnology Market Size by Application (2025-2030)
8.3.3 China Red Biotechnology Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Red Biotechnology Market Size (2019-2030)
9.2 Asia Red Biotechnology Market Size by Type
9.2.1 Asia Red Biotechnology Market Size by Type (2019-2024)
9.2.2 Asia Red Biotechnology Market Size by Type (2025-2030)
9.2.3 Asia Red Biotechnology Market Share by Type (2019-2030)
9.3 Asia Red Biotechnology Market Size by Application
9.3.1 Asia Red Biotechnology Market Size by Application (2019-2024)
9.3.2 Asia Red Biotechnology Market Size by Application (2025-2030)
9.3.3 Asia Red Biotechnology Market Share by Application (2019-2030)
9.4 Asia Red Biotechnology Market Size by Region
9.4.1 Asia Red Biotechnology Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Red Biotechnology Market Size by Region (2019-2024)
9.4.3 Asia Red Biotechnology Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Red Biotechnology Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Red Biotechnology Market Size by Type
10.2.1 Middle East, Africa, and Latin America Red Biotechnology Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Red Biotechnology Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Red Biotechnology Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Red Biotechnology Market Size by Application
10.3.1 Middle East, Africa, and Latin America Red Biotechnology Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Red Biotechnology Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Red Biotechnology Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Red Biotechnology Market Size by Country
10.4.1 Middle East, Africa, and Latin America Red Biotechnology Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Red Biotechnology Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Red Biotechnology Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Red Biotechnology Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Red Biotechnology Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Red Biotechnology Introduction
11.2.4 Amgen Revenue in Red Biotechnology Business (2019-2024)
11.2.5 Amgen Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Red Biotechnology Introduction
11.3.4 Gilead Sciences Revenue in Red Biotechnology Business (2019-2024)
11.3.5 Gilead Sciences Recent Developments
11.4 CSL
11.4.1 CSL Company Details
11.4.2 CSL Business Overview
11.4.3 CSL Red Biotechnology Introduction
11.4.4 CSL Revenue in Red Biotechnology Business (2019-2024)
11.4.5 CSL Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Red Biotechnology Introduction
11.5.4 Pfizer Revenue in Red Biotechnology Business (2019-2024)
11.5.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂